EXERCISE TOLERANCE INCREASED

EXERCISE TOLERANCE INCREASED was reported 43 times

EXERCISE TOLERANCE INCREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 Phosphodiesterase 3 Inhibitor [EPC] 1 0.0002
2 Soluble Guanylate Cyclase Stimulator [EPC] 2 0.0001
3 Purine Antimetabolite [EPC] 5 0.0001
4 5-alpha Reductase Inhibitor [EPC] 4 0.0000
5 PCSK9 Inhibitor [EPC] 1 0.0000
6 Prostacyclin Receptor Agonist [EPC] 1 0.0000
7 Anti-IgE [EPC] 3 0.0000
8 Provitamin D2 Compound [EPC] 1 0.0000
9 Aldosterone Antagonist [EPC] 5 0.0000
10 Prostacycline Vasodilator [EPC] 4 0.0000
11 Cholinergic Muscarinic Antagonist [EPC] 1 0.0000
12 P2Y12 Platelet Inhibitor [EPC] 3 0.0000
13 Endothelin Receptor Antagonist [EPC] 5 0.0000
14 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
15 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
16 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
17 Nicotinic Acid [EPC] 1 0.0000
18 Angiotensin 2 Receptor Blocker [EPC] 5 0.0000
19 Phosphodiesterase 5 Inhibitor [EPC] 2 0.0000
20 Loop Diuretic [EPC] 4 0.0000
21 Corticosteroid [EPC] 10 0.0000
22 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
23 alpha-Adrenergic Blocker [EPC] 1 0.0000
24 Calcium [EPC] 1 0.0000
25 Azole Antifungal [EPC] 1 0.0000
26 Janus Kinase Inhibitor [EPC] 1 0.0000
27 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
28 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
29 Interleukin-4 Receptor alpha Antagonist [EPC] 3 0.0000
30 Folate Analog Metabolic Inhibitor [EPC] 2 0.0000
31 beta-Adrenergic Blocker [EPC] 1 0.0000
32 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
33 Nonsteroidal Anti-inflammatory Drug [EPC] 3 0.0000
34 Insulin Analog [EPC] 1 0.0000
35 Platelet Aggregation Inhibitor [EPC] 1 0.0000
36 Proton Pump Inhibitor [EPC] 1 0.0000
37 Benzodiazepine [EPC] 1 0.0000